When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Mereo BioPharma Group’s stock has appreciated nicely since pricing a highly-dilutive secondary on Feb. 10, 2021.
Although nearly uncovered by the Street, the company made headlines in December 2020 when it inked a collaboration with Ultragenyx that included $50 million upfront.
With ongoing negotiations for two other "non-core" assets, data from its two wholly-owned assets due in 2H21, and an impressive roster of 13D/G owners, Mereo merited a deeper dive.